STOCK TITAN

Korro Bio: Venrock group reports 9.99% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Korro Bio, Inc. (KRRO) ownership amendment reports that Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Y. Koh share reported beneficial ownership of 1,474,162 shares as of September 30, 2026, or 9.99% of the class. The report identifies Shah and Koh as voting members of the two management entities. Each of the seven reporting persons reports the same shared amount.

The listed positions include 198,756 common shares and pre-funded warrants exercisable for up to 426,762 shares at VHCP III; 19,895 common shares and warrants exercisable for up to 42,597 shares at VHCP Co-Investment III; and 224,780 common shares and warrants exercisable for up to 2,176,406 shares at VHCP EG. The warrants have a blocker that prevents exercise to the extent it would put group beneficial ownership above 9.99%; the report says exercise was prohibited to the extent ownership would exceed 1,474,162 shares. Korro Bio had 13,725,646 shares outstanding as of September 30, 2026. The cover pages display 9.9%, which the report says was rounded down because of EDGAR field limits.

Reported beneficial ownership 1,474,162 shares Same shared amount reported by each reporting person as of September 30, 2026
Beneficial ownership percentage 9.99% As of September 30, 2026; cover pages display 9.9% after rounding down
Common shares outstanding 13,725,646 shares As of September 30, 2026
VHCP III listed position 198,756 common shares; pre-funded warrants exercisable for up to 426,762 shares Held by Venrock Healthcare Capital Partners III, L.P.
VHCP Co-Investment III listed position 19,895 common shares; pre-funded warrants exercisable for up to 42,597 shares Held by VHCP Co-Investment Holdings III, LLC
VHCP EG listed position 224,780 common shares; pre-funded warrants exercisable for up to 2,176,406 shares Held by Venrock Healthcare Capital Partners EG, L.P.
Pre-Funded Warrants financial
"Pre-Funded Warrants exercisable for up to 426,762 shares of common stock"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Beneficial Ownership Blocker financial
"provision (the "Beneficial Ownership Blocker")"
A beneficial ownership blocker is a legal or structural device that prevents a shareholder from being treated as the ultimate owner of enough shares to trigger control, reporting, or voting thresholds. Think of it like a speed bump that stops an investor from reaching a stake size that would force corporate disclosure or change control rights. Investors care because it affects who controls the company, how shares vote, regulatory filings, takeover risk and therefore potential value or liquidity of their holdings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much of KRRO did the reporting persons beneficially own?

Each of the seven reporting persons reported shared beneficial ownership of 1,474,162 shares as of September 30, 2026, representing 9.99% of the class. The cover pages show 9.9%, which the report says was rounded down because of EDGAR field limits.

How does the KRRO pre-funded warrant ownership blocker work?

The blocker prevents exercise of pre-funded warrants to the extent exercise would cause the reporting group, together with affiliates and other attribution parties, to own more than 9.99% of Korro Bio’s common stock. The report says exercise was prohibited to the extent it would result in beneficial ownership of more than 1,474,162 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





500946108

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Venrock Healthcare Capital Partners III, L.P.
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
VHCP Co-Investment Holdings III, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management III, LLC, its Manager, By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
Venrock Healthcare Capital Partners EG, L.P.
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management EG, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
VHCP Management III, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
VHCP Management EG, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
Nimish Shah
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Attorney-in-fact
Date:11/16/2026
Bong Y. Koh
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Attorney-in-fact
Date:11/16/2026
Exhibit Information

Exhibit 24.1 Power of Attorney for Bong Y. Koh (incorporated by reference to Exhibit 24.1 to the Reporting Persons' Schedule 13G filed with the SEC on March 17, 2026). Exhibit 24.2 Power of Attorney for Nimish P. Shah (incorporated by reference to Exhibit 24.2 to the Reporting Persons' Schedule 13G filed with the SEC on March 17, 2026). Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on March 17, 2026).

Keep reading